Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
Eva Konkoľová, Monika Hudáčová, Slávka Hamuľaková, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 1133-1133
Open Access | Times Cited: 18

Showing 18 citing articles:

Research progress of coumarins and their derivatives in the treatment of diabetes
Yinbo Pan, Teng Liu, Xiaojing Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 616-628
Open Access | Times Cited: 40
Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma
Eman M. Radwan, Eman Abo-Elabass, Atef E. Abd El-Baky, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10
Coumarin-heterocycle framework: A privileged approach in promising anticancer drug design
Atukuri Dorababu
European Journal of Medicinal Chemistry Reports (2021) Vol. 2, pp. 100006-100006
Open Access | Times Cited: 18
Acridine derivatives as inhibitors/poisons of topoisomerase II
Mária Kožurková
Journal of Applied Toxicology (2021) Vol. 42, Iss. 4, pp. 544-552
Closed Access | Times Cited: 14
Facile Synthesis of Some Coumarin Derivatives and Their Cytotoxicity through VEGFR2 and Topoisomerase II Inhibition
Mohamed S. Gomaa, Imran Ali, Gaber El Enany, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8279-8279
Open Access | Times Cited: 10
Novel diarylated tacrine derivatives: Synthesis, characterization, anticancer, antiepileptic, antibacterial, and antifungal activities
Büşra Albayrak Mısır, Yavuz Deri̇n, Salih Ökten, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 4
Open Access | Times Cited: 1
Interaction of tacrine-coumarin derivatives with double stranded DNA: spectroscopic and molecular docking study
Eva Konkoľová, Monika Hudáčová, Slávka Hamuľaková, et al.
Chemical Papers (2023) Vol. 77, Iss. 7, pp. 3993-4006
Closed Access | Times Cited: 4
Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer
Limeng Wu, Wenjie Liu, Yaoguang Huang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114701-114701
Closed Access | Times Cited: 7
Synthesis of 7‐{[2‐(4‐ substituted phenyl)‐2‐oxoethyl] amino}‐4‐methyl‐2H‐1‐benzopyran‐2‐one derivatives and evaluation of their pharmacological activities
G. V. Megha, Yadav D. Bodke
ChemistrySelect (2024) Vol. 9, Iss. 5
Closed Access
Novel coumarin-piperazine-2(5H)-furanone hybrids as potential anti-lung cancer agents: Synthesis, biological evaluation and molecular docking studies
Sisi Zhang, Yu He, Meng‐Xue Wei
Fitoterapia (2024) Vol. 177, pp. 106105-106105
Closed Access
Exploring the therapeutic potential of acridines: Synthesis, structure, and biological applications
Diego Santa Clara Marques, Lisandra da Silva Lima, Josué Filipe de Oliveira Moraes Miranda, et al.
Bioorganic Chemistry (2024) Vol. 155, pp. 108096-108096
Closed Access
Recent Perspectives on Anticancer Potential of Coumarin Against Different Human Malignancies: An Updated Review
Muhammad Shahbaz, Asfa Perween, Ushna Momal, et al.
Food Science & Nutrition (2024) Vol. 13, Iss. 1
Open Access
Fragment‐type 4‐azolylcoumarin derivatives with anticancer properties
Milena Simić, Miloš Petković, Predrag Jovanović, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 11
Closed Access | Times Cited: 4
Design, Synthesis, Molecular Docking and Cytotoxicity of Stilbene-arylcinnamide Hybrids on A549 Lung Cancer Cells
Nurain Syazwani Mohd. Zaki, Nik Nur Syazni Nik Mohamad Kamal, Unang Supratman, et al.
Current Organic Chemistry (2023) Vol. 27, Iss. 16, pp. 1458-1470
Closed Access | Times Cited: 1
Novel drug discovery against breast and lung cancer using pharmacophore based 2H-1-benzopyran-2-one derivative
Nidhi Mishra, Akhilesh Kumar Maurya
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Preparation and Synergistic Anti-Tumor Effect of Iridium Oxide Nanocomposites under Microscope
Xudong He, Feng Xiang, Zhangyi Xu
International Journal of Analytical Chemistry (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 1
Anticancer Inhibitors
Alessandra Ammazzalorso, Marialuigia Fantacuzzi
Molecules (2022) Vol. 27, Iss. 14, pp. 4650-4650
Open Access | Times Cited: 1
Synthesis, SAR, and in Silico ADME Screening Studies of Some 9-Amino-3-Phenylacridone Derivatives as Topoisomerase II Inhibitors
Abiodun S. Oyedele, Toluwase Hezekiah Fatoki, Esha D. Dalvie, et al.
Open Journal of Medicinal Chemistry (2023) Vol. 13, Iss. 02, pp. 15-34
Open Access
Page 1

Scroll to top